Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
INTERCEPT PHARMACEUTICALS, INC. (ICPT) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/02/2023 8-K Quarterly results
05/25/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
04/27/2023 8-K Quarterly results
03/24/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "SALES AGREEMENT",
"Letter re: Intercept Pharmaceuticals, Inc. Registration Statement on Form S-3ASR"
03/02/2023 8-K Quarterly results
Docs: "Intercept Pharmaceuticals, Inc. Condensed Consolidated Statements of Operations"
02/27/2023 8-K Other Events  Interactive Data
02/02/2023 8-K Quarterly results
01/25/2023 8-K Other Events  Interactive Data
01/19/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "FDA Accepts Intercept’ s New Drug Application for OCA for the Treatment of Pre-Cirrhotic Liver Fibrosis Due to NASH"
01/17/2023 8-K Other Events  Interactive Data
01/11/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Presentation"
12/23/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Intercept Resubmits New Drug Application to U.S. FDA for Obeticholic Acid in Patients with Liver Fibrosis due to NASH"
11/01/2022 8-K Quarterly results
09/30/2022 8-K Quarterly results
09/21/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Intercept Pharmaceuticals Announces Summary of Key Actions in Strategic Financial Repositioning"
09/20/2022 8-K Other Events  Interactive Data
09/12/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
09/08/2022 8-K Unregistered Sales of Equity Securities  Interactive Data
09/07/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
09/06/2022 8-K Unregistered Sales of Equity Securities  Interactive Data
09/02/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
08/26/2022 8-K Unregistered Sales of Equity Securities  Interactive Data
08/19/2022 8-K Quarterly results
08/16/2022 8-K Quarterly results
08/03/2022 8-K Quarterly results
Docs: "Intercept Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update"
07/26/2022 8-K Other Events  Interactive Data
07/08/2022 8-K Quarterly results
07/07/2022 8-K Quarterly results
07/01/2022 8-K Quarterly results
06/21/2022 8-K Quarterly results
06/06/2022 8-K Quarterly results
06/03/2022 8-K Quarterly results
06/02/2022 8-K Quarterly results
05/25/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy